Maculaser Ltd
Restoring retinal health
Restoring retinal health
Maculaser is a Finnish-based startup founded in 2020, with a clear mission encapsulated in their slogan: Restoring retinal health. The company specializes in developing revolutionary medical technology tailored for treating common retinal diseases, particularly dry Age-related Macular Degeneration. Maculaser's proprietary innovation is centered around the precise temperature control of the macula during non-damaging laser treatments, potentially revolutionizing the treatment landscape for major retinal diseases, which currently incur over USD 400B in direct healthcare costs. This innovation opens up new possibilities for clinicians in delivering laser therapy, offering a ray of hope to millions in retaining their vision. The company recently secured a $1.20M in Seed Round investment on 15 February 2021, with Innovestor being the lead investor. Operating in the manufacturing industry, Maculaser holds the promise of reshaping the future of retinal healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $1.20M | 1 |
|
15 Feb 2021 |
No recent news or press coverage available for Maculaser Ltd.
We care about your data, and we'd love to use cookies make your experience better.
